Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials

Alessandro Armuzzi, Roberto Lorenzetti, Angelo Zullo, Lorenzo Ridola, Andrea Picchianti Diamanti, Bruno Laganà, Luigi Gatta, Alberto Migliore, Cesare Hassan, Vincenzo Bruzzese

Risultato della ricerca: Contributo in rivistaArticolo in rivista

57 Citazioni (Scopus)

Abstract

Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies.
Lingua originaleEnglish
pagine (da-a)547-554
Numero di pagine8
RivistaAnnals of Medicine
Volume46
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • Ankylosing spondylitis
  • anti-TNF
  • inflammatory bowel diseases
  • methotrexate
  • psoriasis
  • rheumatoid arthritis
  • tuberculosis

Fingerprint

Entra nei temi di ricerca di 'Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials'. Insieme formano una fingerprint unica.

Cita questo